Rein Therapeutics (RNTX) Operating Leases (2019 - 2022)
Rein Therapeutics (RNTX) posted quarterly Operating Leases of $217000.0 for Q3 2022, up 119.19% year-over-year from $99000.0 in Q3 2021, and little changed quarter-over-quarter from $217000.0 in Q2 2022.
Rein Therapeutics (RNTX) Operating Leases (2019 - 2022) Analysis & Trends
Rein Therapeutics (RNTX) has reported Operating Leases for 4 consecutive years, with $217000.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Operating Leases rose 119.19% year-over-year to $217000.0; the TTM figure through Sep 2022 stood at $217000.0 (up 119.19% YoY), while the FY2021 annual figure was $69000.0, changed N/A from the prior year.
- Operating Leases held at $217000.0 in Q3 2022 per RNTX's latest filing, from $217000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $4.9 million in Q1 2019 and bottomed at $69000.0 in Q4 2021.
- Historically, Operating Leases has averaged $2.4 million across 4 years, with a median of $2.2 million in 2020.
- Annual changes were most pronounced in 2021 — Operating Leases slumped 97.64% — and 2022, when it jumped 119.19%.
- Rein Therapeutics' Operating Leases stood at $4.6 million in 2019, then decreased by 8.5% to $4.2 million in 2020, then plunged by 98.36% to $69000.0 in 2021, then soared by 214.49% to $217000.0 in 2022.
- Business Quant data shows RNTX's Operating Leases at $217000.0 in Q3 2022, $217000.0 in Q2 2022, and $217000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Rein Therapeutics | 55.30 Mn | 55.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 217,000.00 |
| Jun 30, 2022 | 217,000.00 |
| Mar 31, 2022 | 217,000.00 |
| Dec 31, 2021 | 69,000.00 |
| Sep 30, 2021 | 99,000.00 |
| Jun 30, 2021 | 128,000.00 |
| Mar 31, 2021 | 124,000.00 |
| Sep 30, 2020 | 4.20 Mn |
| Jun 30, 2020 | 4.33 Mn |
| Mar 31, 2020 | 4.46 Mn |
| Dec 31, 2019 | 4.59 Mn |
| Sep 30, 2019 | 4.71 Mn |
| Jun 30, 2019 | 4.82 Mn |
| Mar 31, 2019 | 4.93 Mn |